{"id":40078,"date":"2017-04-08T12:14:09","date_gmt":"2017-04-08T17:14:09","guid":{"rendered":""},"modified":"2025-12-15T09:57:49","modified_gmt":"2025-12-15T14:57:49","slug":"synoptic-pathology-reporting","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/synoptic-pathology-reporting\/","title":{"rendered":"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques"},"content":{"rendered":"<p>Ce rapport \u00e9value la mise en \u0153uvre des syst\u00e8mes \u00e9lectroniques et des normes en mati\u00e8re de pathologie en Ontario, au Nouveau-Brunswick, en Nouvelle-\u00c9cosse, \u00e0 l\u2019\u00cele-du-Prince-\u00c9douard, en Colombie-Britannique et au Manitoba. Cette \u00e9valuation comprend les \u00e9l\u00e9ments qui ont bien fonctionn\u00e9, ce qui aurait pu \u00eatre fait diff\u00e9remment, ainsi que les principaux facteurs favorables et les principaux obstacles.<\/p>\n<p>De plus, ce rapport examine les fa\u00e7ons d\u2019appuyer la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques, les indicateurs pour \u00e9valuer les rapports de chaque territoire de comp\u00e9tence et l\u2019atteinte ou non des objectifs de l\u2019initiative.<\/p>\n<p>Les objectifs de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques (IPRSAE) sont\u00a0:<\/p>\n<ol>\n<li>soutenir l\u2019adoption des rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques pour les cancers du sein, colorectal, du poumon, de la prostate et de l\u2019endom\u00e8tre;<\/li>\n<li>maintenir et promouvoir l\u2019adoption des normes;<\/li>\n<li>se servir des indicateurs de performance pour promouvoir l\u2019utilisation des donn\u00e9es normalis\u00e9es.<\/li>\n<\/ol>\n<p>L\u2019IPRSAE a contribu\u00e9 \u00e0 la lutte contre le cancer au Canada gr\u00e2ce \u00e0 des mesures coh\u00e9rentes qui appuient des diagnostics et des soins cliniques de grande qualit\u00e9\u00a0:<\/p>\n<ul>\n<li>l\u2019Ontario, le Nouveau-Brunswick, la Nouvelle-\u00c9cosse, l\u2019\u00cele-du-Prince-\u00c9douard, la Colombie-Britannique et le Manitoba ont les moyens de consigner des donn\u00e9es normalis\u00e9es et exhaustives concernant la pathologie, le diagnostic, la stadification et le pronostic, en mettant en \u0153uvre les protocoles normalis\u00e9s en mati\u00e8re de pathologie (\u00e9labor\u00e9s par le CAP dans ses syst\u00e8mes d\u2019information).<\/li>\n<li>Un total de 850\u00a0pathologistes canadiens (67\u00a0%) ont maintenant fait la transition du format narratif au format \u00e9lectronique pour les rapports dans ces six provinces.<\/li>\n<li>Les syst\u00e8mes de sant\u00e9 provinciaux et r\u00e9gionaux, les organismes de lutte contre le cancer, les pathologistes et les autres cliniciens peuvent maintenant acc\u00e9der aux donn\u00e9es sur les diagnostics, la stadification et le traitement afin d\u2019examiner la r\u00e9partition de l\u2019anatomie des cellules canc\u00e9reuses, la mesure dans laquelle les cellules canc\u00e9reuses se propagent, le potentiel de r\u00e9cidive du cancer, le pronostic du patient et la survie. Ces renseignements n\u2019\u00e9taient pas accessibles avant la mise en \u0153uvre de l\u2019IPRSAE.<\/li>\n<\/ul>\n<div class=\"related-stats orange col-sm-12 col-md-12 col-lg-12 display-left\"><div class=\"stats-header\">67 %<\/div>   <div class=\"stats-sub-header\">des pathologistes ont fait la transition au format \u00e9lectronique<\/div>\n                    <\/div>\n<p>Le but de ce rapport est d\u2019obtenir des renseignements des six provinces au sujet des principaux facteurs favorables et des principaux obstacles dans quatre domaines li\u00e9s \u00e0 l\u2019IPRSAE et de savoir si les objectifs ont \u00e9t\u00e9 atteints\u00a0:<\/p>\n<ul>\n<li>mise en \u0153uvre du programme;<\/li>\n<li>mobilisation;<\/li>\n<li>exp\u00e9rience des intervenants;<\/li>\n<\/ul>\n<p>Les entrevues avec les informateurs, les sondages et les examens de la documentation cl\u00e9s ont \u00e9t\u00e9 inclus dans ce rapport. Les constatations du rapport peuvent nous aider \u00e0 tirer profit de l\u2019exp\u00e9rience, \u00e0 trouver des fa\u00e7ons de surmonter les obstacles, \u00e0 assurer la p\u00e9rennit\u00e9 de l\u2019IPRSAE, \u00e0 \u00e9clairer la planification future du Partenariat, en plus d\u2019aider d\u2019autres territoires de comp\u00e9tence \u00e0 adopter l\u2019IPRSAE.<\/p>\n<p>Les recommandations du rapport peuvent \u00eatre utiles, notamment en\u00a0:<\/p>\n<ul>\n<li>favorisant l\u2019utilisation de la pathologie normalis\u00e9e dans la pratique clinique afin d\u2019am\u00e9liorer la qualit\u00e9 des diagnostics, de la stadification et du traitement des cancers;<\/li>\n<li>am\u00e9liorant les plans op\u00e9rationnels visant le maintien de l\u2019IPRSAE dans six provinces;<\/li>\n<li>mettant l\u2019IPRSAE en \u0153uvre dans des provinces potentielles;<\/li>\n<li>analysant les solutions pour normaliser les processus des soins du cancer \u00e0 l\u2019aide des technologies de l\u2019information.<\/li>\n<\/ul>\n<p><strong>Document \u00e0 t\u00e9l\u00e9charger <\/strong>(en anglais seulement)<\/p>\n<div class=\"documents col-md-12\"><div>\n                                <i class=\"fas fa-file-pdf document-icon\"><\/i>\n                                <div class=\"document-details\">\n                                    <a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2019\/01\/Electronic-Synoptic-Pathology-Reporting-Initiative-Eval-2017-EN.pdf\" target=\"_blank\">Evaluation of the electronic synoptic pathology reporting initiative implementation<\/a><p class=\"file-information\">Taille du fichier 1 MB<\/p>         <\/div>\n                            <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ce rapport \u00e9value la mise en \u0153uvre des syst\u00e8mes \u00e9lectroniques et des normes en mati\u00e8re de pathologie en Ontario, au Nouveau-Brunswick, en Nouvelle-\u00c9cosse, \u00e0 l\u2019\u00cele-du-Prince-\u00c9douard, en Colombie-Britannique et au Manitoba. Cette \u00e9valuation comprend les \u00e9l\u00e9ments qui ont bien fonctionn\u00e9, ce qui aurait pu \u00eatre fait diff\u00e9remment, ainsi que les principaux facteurs favorables et les principaux [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"template":"","topics_tags":[1756],"type-of-care":[1641],"cancer-continuum":[1648,1649,1643],"cancer-system-measurement":[],"dbt-cancer-site":[475,1807,480,488,510,472],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-40078","topics","type-topics","status-publish","hentry","topics_tags-colombie-britannique","type-of-care-pathology-fr","cancer-continuum-diagnosis-fr","cancer-continuum-staging-fr","cancer-continuum-treatment-fr","dbt-cancer-site-dbv-colorectal-fr","dbt-cancer-site-dbv-endometrial-fr","dbt-cancer-site-dbv-gynecology-fr","dbt-cancer-site-dbv-lung-fr","dbt-cancer-site-dbv-prostate-fr","dbt-cancer-site-dbv-breast-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Ce rapport \u00e9value la mise en \u0153uvre des syst\u00e8mes \u00e9lectroniques et des normes en mati\u00e8re de pathologie en Ontario, au Nouveau-Brunswick, en Nouvelle-\u00c9cosse, \u00e0 l\u2019\u00cele-du-Prince-\u00c9douard, en Colombie-Britannique et au Manitoba. Cette \u00e9valuation comprend les \u00e9l\u00e9ments qui ont bien fonctionn\u00e9, ce qui aurait pu \u00eatre fait diff\u00e9remment, ainsi que les principaux facteurs favorables et les principaux [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&amp;p=40078\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-15T14:57:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40078\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40078\",\"name\":\"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2017-04-08T17:14:09+00:00\",\"dateModified\":\"2025-12-15T14:57:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40078#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40078\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/?post_type=topics&p=40078#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques - Canadian Partnership Against Cancer","og_description":"Ce rapport \u00e9value la mise en \u0153uvre des syst\u00e8mes \u00e9lectroniques et des normes en mati\u00e8re de pathologie en Ontario, au Nouveau-Brunswick, en Nouvelle-\u00c9cosse, \u00e0 l\u2019\u00cele-du-Prince-\u00c9douard, en Colombie-Britannique et au Manitoba. Cette \u00e9valuation comprend les \u00e9l\u00e9ments qui ont bien fonctionn\u00e9, ce qui aurait pu \u00eatre fait diff\u00e9remment, ainsi que les principaux facteurs favorables et les principaux [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-12-15T14:57:49+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078","name":"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2017-04-08T17:14:09+00:00","dateModified":"2025-12-15T14:57:49+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/?post_type=topics&p=40078#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"\u00c9valuation de l\u2019Initiative sur la production de rapports synoptiques d\u2019anatomopathologie \u00e9lectroniques"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/40078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=40078"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=40078"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=40078"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=40078"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=40078"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=40078"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=40078"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=40078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}